Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
D

DOD Biotech PCL
SET:DOD

Watchlist Manager
DOD Biotech PCL
SET:DOD
Watchlist
Price: 0.78 THB 8.33% Market Closed
Market Cap: ฿351.3m
Write Note Create Alert Ask AI

Wall St Price Targets

DOD Price Targets Summary
DOD Biotech PCL

There are no price targets for DOD.
DOD Lowest Forecast
Wall Street Target
Not Available
DOD Average Forecast
Wall Street Target
Not Available
DOD Highest Forecast
Wall Street Target
Not Available
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
DOD Biotech PCL Competitors:
Price Targets

Revenue
Forecast

5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
5% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Revenue Forecast
is not available for DOD Biotech PCL

Gross Profit
Forecast

1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for DOD Biotech PCL

Operating Income
Forecast

-10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-10% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Operating Income Forecast
is not available for DOD Biotech PCL

Pre-Tax Income
Forecast

-11% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-11% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for DOD Biotech PCL

Net Income
Forecast

-7% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-7% / Year
Past Growth
26% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 10 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 7 years is 26%.

What are analyst estimates?

Continue DOD Research

Summary
DOD intrinsic value, competitors valuation, and company profile.
DCF Valuation
DOD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DOD stock valuation using valuation multiples.
Wall St Estimates
DOD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DOD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DOD's stock price target?
Not Available

DOD does not have any price targets made by Wall Street professionals.

What is the Net Income forecast for DOD Biotech PCL?
Projected CAGR
26%

Over the last 10 years, the compound annual growth rate for Net Income has been -7%. The projected CAGR for the next 7 years is 26%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.